TLDR
- ARK Invest purchased 34,080 Meta Platforms shares valued at $20.55 million on July 9, 2026
- The acquisition preceded Meta’s anticipated Q2 earnings announcement scheduled for July 29
- ARK divested 10,774 AMD shares worth $5.57 million, extending its week-long position reduction
- The firm also purchased 217,896 Circle Internet Group shares spanning three ETFs totaling $13.96 million
- Analysts assign Meta a Strong Buy consensus with a mean price target of $817.15
On Thursday, July 9, 2026, Cathie Wood’s ARK Invest executed several significant portfolio adjustments. The most substantial transaction involved a $20.55 million acquisition of Meta Platforms shares via the ARK Innovation ETF.
The investment firm secured 34,080 Meta shares. This strategic purchase occurred mere weeks prior to Meta’s scheduled second-quarter earnings disclosure on July 29.
Analysts on Wall Street are projecting Meta to deliver earnings of $7.17 per share alongside revenue reaching $60.19 billion for the reporting period.
Strategic Investment Amid Meta’s Artificial Intelligence Expansion
The share acquisition followed several significant artificial intelligence initiatives from Meta. The tech giant introduced Muse Spark 1.1, marking its inaugural commercial AI model, while rolling out additional AI-powered business solutions.
Meta revealed that Iris, its proprietary AI chip, is scheduled to enter mass production this September. Additionally, the corporation disclosed intentions to allocate over $13 billion toward constructing a cutting-edge data center facility in Alberta, Canada.
According to TipRanks data, Meta maintains a Strong Buy consensus rating derived from 34 Buy recommendations and five Hold assessments. The consensus price target of $817.15 suggests potential upside of approximately 29.4% from present trading levels. Meta’s stock has declined 4.2% since the beginning of the year.
AMD Position Reduced Alongside Other Divestitures
Regarding sales activity, ARK liquidated 10,774 Advanced Micro Devices shares through its ARKK ETF. This transaction represented $5.57 million in value. The AMD sale continues a systematic reduction pattern, with ARK decreasing its stake throughout the previous week.
Additionally, ARK divested 85,319 Robinhood Markets shares valued at $9.69 million and 70,154 Roku shares totaling $9.77 million.
The firm also reduced its Twist Bioscience holdings, selling 98,776 shares for $8.83 million.
Beyond the Meta purchase, ARK expanded its Circle Internet Group holdings. The firm acquired 217,896 shares distributed across its ARKK, ARKW, and ARKF ETFs, amounting to $13.96 million collectively.
ARK additionally secured 105,364 Ionis Pharmaceuticals shares valued at $8.9 million and 544,385 Prime Medicine shares for $2.52 million.
Smaller acquisitions encompassed 57,462 Generate Biomedicines shares totaling $911,921 and 46,302 Compass Pathways shares worth $646,838.
Following the public disclosure of ARK’s transaction, Meta stock surged 6.58% on July 10.





